Abstruct
In situ hybridization is a method used to localize nucleic acid sequences in cells or tissue sections. The first in situ hybridization experiments were described by two groups of researchers in 1969, John et al. and Gall and Pardue (reviewed in ref. 1). Radioactively labeled RNA probes were used to localize specific DNA sequences within the nuclei of Xenopus laevis (2).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Warford, A. (1994) An overview of in situ hybridisation, in A Guide to In Situ Hybaid, UK, pp. 5–17.
John, H. A, Birnstiel, M. L., and Jones, K. W. (1969) RNA-DNA hybrids at the cytological level. Nature 223, 582–587.
Herrington, C. S. (1998) Demystified...in situ hybridisation. J. Clin. Pathol: Mol. Pathol. 51, 8–13.
Williams, C., Ponten, F., Moberg, C., et al (1999) A high frequency of sequence alterations is due to formalin fixation of archival specimens. Am. J. Pathol. 155, 1467–1471.
Hopman, A. H. N., Ramaekers, F. C. S., Raap, A. K., et al. (1988) In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 89, 307–316.
Hopman, A. H. N., van Hooren, E., van de Kaa, C. A., Vooijs, P. G. P., and Ramaekers, F. C. S. (1991) Detection of numerical chromosome aberrations using in situ hybridization in paraffin sections of routinely processed bladder cancers. Mod. Pathol. 4, 503–512.
Sauter, G., Moch, H., Wagner, U., et al (1995) Y chromosome loss detected by FISH in bladder cancer. Cancer Genet. Cytogenet. 82, 163–169.
Murphy, D. S., McHardy P., Coutts, J.. et al. (1995) Interphase cytogenetic analysis of erbB2 and topoII? co-amplification in invasive breast cancer and polysomy of chromosome 17 in ductal carcinoma in situ. Int. J. Cancer 64, 18–26.
Wolf, N. G., Abdul-Karim, F. W., Schork, N. J., and Schwartz, S. (1996) Origins of heterogeneous ovarian carcinomas. A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components. Am. J. Pathol. 149, 511–520.
Lawrence Fox, J., Hsu, P-H., Legator, M., Morrison, L. E., and Seelig, S. A. (1995) Fluorescence in situ hybridisation: powerful molecular tool for cancer progniosis. Clin. Chem. 41, 1554–1559.
McNicol, A. M. and Farquharson, M. (1997) In situ hybridisation and its diagnostic applications in pathology. J. Pathol. 182, 250–261.
Poulsom, R. (2001) In situ hybridisation to localise mRNAs, in Metastasis Methods & Protocols (Brooks, S. A. and Schumacher, U., eds.), Humana, Totowa, NJ, pp. 177–198.
Poetsch, M., Dittberner, T., Woenckhaus, C., and Kleist, B. (2000) Use of interphase cytogenetics in demonstrating specific chromosomal aberrations in solid tumors-new insights in the pathogenesis of malignant melanoma and head and neck squamous cell carcinoma. Histol. Histopathol. 15, 1225–1231.
Herrington, C. S. and McGee, J. O.'D.(1992) Principles and basic methodology of DNA/RNA detection by in situ hybridisation, in Diagnostic Molecular Pathology, A Practical Approach, Volume I (Herrington, C. S. and McGee, J. O.'D, eds.), Oxford University Press, Oxford.
Bartlett, J. M. S., Watters, A. D., Going, J. J., Ballantyne, S. A., Grigor, K. M., and Cooke, T. G. (1998) Quantitative FISH: is chromosome 9 loss a marker of disease recurrence in TCC of the bladder? Br. J. Cancer 77, 2193–2198.
Watters, A. D., Ballantyne, S. A., Going, J. J., Grigor, K. M., Cooke, T. G., and Bartlett, J. M. S. (2000) Aneusomy of chromosomes 7 & 17 predicts recurrence of transitional cell carcinoma of the urinary bladder. Br. J. Urol. 85, 42–47.
Watters, A. D. and Bartlett, J. M. S. (2000) Quantitation of FISH signals in archival tumours, in Ovarian Cancer: Methods and Protocols (Bartlett, J. M. S., ed.), Humana, Totowa, NJ, Vol. 3, pp. 253–260.
Syrjanen, S. (1992) Viral gene detection by in situ hybridisation, in Diagnostic Molecular Pathology, A Practical Approach, Volume I (Herrington, C. S. and McGee, J. O'D., eds.), Oxford University Press, Oxford.
Hopwood, D. (1996) Fixation and fixatives, in Theory and Practice of Histological Techniques, 4th ed., (ai]Bancroft, J. and Stevens, A., eds.), Churchill Livingstone, London.
McKenzie, K. J., Ferrier, R. K., Howatson, A. G., and Lindop, G. B. M. (1996) Demonstration of renin gene expression in nephroblastoma by in situ hybridisation. J. Pathol. 180, 71–73.
Watters, A. D. and Bartlett, J. M. S. (2002) Fluorescence in situ hybridization in paraffin tissue sections: pretreatment protocol. Mol. Biotechnol. 21, 217–220.
Leitch, A. R., Schwarzacher, T., Jackson, D., and Leitch, I. J. (1994) In Situ Hybridisation. BIOS Scientific, Oxford.
Mitchell, B. S., Dhami, D., and Schumacher, U. (1992) In situ hybridisation: a review of methodologies and applications in the biomedical sciences. Med. Lab. Sci. 49, 107–118.
Roche Diagnostics (2002) DIG Application Manual for Non-Radioactive In Situ Hybridisation, 3rd ed. Roche Diagnostics.
Arber, D. A. (2000) Molecular diagnostic approach to non-Hodgkin’s lymphoma. J. Mol. Diagn. 2, 178–190.
Pauletti, G., Godolphin, W., Press, M. F., and Slamon, D. J. (1996) Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13, 63–72.
Haralambieva, E., Kleiverda, K., Mason, D. Y., Schuuring, E., and Kluin, P. M. (2002) Detection of three common translocation breakpoints in non-Hodgkin’s lymphomas by fluorescence in situ hybridisation on routine paraffin-embedded tissue sections. J. Pathol. 198, 163–170.
Nomura K., Yoshino, T., Nakamura, S., et al (2003) Detection of t(11;18)(q21;q21) in marginal zone lymphoma of mucosa-associated lymphocytic tissue type on paraffin-embedded tissue sections by using fluorescence in situ hybridisation. Cancer Genet. Cytogenet. 140, 49–54.
Reese, D. M. and Slamon, D. J. (1997) HER2/neu signal transduction in human breast and ovarian cancer. Stem Cells 15, 1–8.
Zujewski, J. O. (2003) “Build quality in”-HER2 testing in the real world. JNCI 94, 788–789.
Rhodes, A., Jasani, B., Couturier, J., et al (2002) A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER2/neu expression in breast cancer. Am. J. Clin. Pathol. 117, 81–89.
Herrington, C. S., Worsham, M., Southern, S. A., et al. (1996) Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J. Pathol. 179, 169–176.
Aldosari, N., Bigner, S. H., Burger, P. C., et al. (2002) MYCC and MYCN oncogene amplification in medulloblastoma: a fluorescence in situ hybridisation study on paraffin sections from the children’s oncology group. Arch. Lab. Med. 126, 540–544.
Halling, K. C., King, W., Sokolova, I. A., et al. (2000) A comparison of cytology and fluorescence in situ hybridisation for the detection of urothelial carcinoma. J. Pathol. 164, 1768–1775.
Lamar Jones, M. (2002) Molecular pathology and in situ hybridisation, in Theory and Practice of Histological Techniques, 5th ed., (Bancroft, J. D. and Gamble, M., eds.), Churchill Livingston, London.
Unger, E. R. and Vernon, S. D. (2001) Detection of human papillomaviruses by polymerase chain reaction and in situ hybridisation, in Methods in Molecular Medicine (Killeen, A. A.,ed.), Humana, Totowa, NJ.
Ramaekers, F. C. S. and Hopman, A. H. N. (1993) Detection of genetic aberrations in bladder cancer using in situ hybridization. Ann. NY Acad. Sci. 677, 199–213.
Poddighe, P. J., Bringuier, P-P., Vallinga, M., Schalken, J. A., Ramaekers, F. C. S., and Hopman, A. H. N. (1996) Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J. Pathol. 179, 169–176.
Russell, A. J., Sibbald, J., Haak, H., Keith, W. N., and McNicol, A. M. (1999) Increasing genomic instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9, and X at the adenoma stage. Br. J. Cancer 81, 684–89.
Speel, E. J. M., Jansen, M. P. H. M., Ramaekers, F. C. S. and Hopman, A. H. N. (1994) A novel triple-color detection procedure for brightfield microscopy, combining in situ hybridization with immunocytochemistry. J. Histochem. Cytochem. 42, 1299–1307.
Botti, C., Pescatore, B., Mottolese, M., et al. (2000) Incidence of chromosomes 1 and 17 aneusomy in breast cancer and adjacent tissue: an interphase cytogenetic study. J. Am. Coll. Surg. 190, 516–525.
Micale, M. A., Visscher, D. W., Gulino, S. E., and Wolman, S. R. (1994) Chromosomal aneuploidy in proliferative breast disease. Hum. Pathol. 25, 29–35.
Steidl, C., Simon, R., Bürger, H., et al. (2002) Patterns of chromosomal aberrations in urinary bladder tumours and adjacent urothelium. J. Pathol. 198, 115–120.
Bubendorf, L., Nocito, A., Moch, H., and Sauter, G. (2001) Tissue microarray (TMA) technology: minaturized pathology archives for high-throughput in situ studies. J. Pathol. 195, 72–79.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Watters, A.D. (2005). In SituHybridization. In: Walker, J.M., Rapley, R. (eds) Medical Biomethods Handbook. Springer Protocols Handbooks. Humana Press. https://doi.org/10.1385/1-59259-870-6:409
Download citation
DOI: https://doi.org/10.1385/1-59259-870-6:409
Publisher Name: Humana Press
Print ISBN: 978-1-58829-288-9
Online ISBN: 978-1-59259-870-0
eBook Packages: Springer Protocols